Literature DB >> 8926393

SAR characteristics of three types of Contact Flexible Microstrip Applicators for superficial hyperthermia.

G Lamaitre1, J D Van Dijk, E A Gelvich, J Wiersma, C J Schneider.   

Abstract

The Effective Field Sizes (EFS) and the Effective Heating Depths (EDH) of Contact Flexible Microstrip Applicators (CFMA), tuned at a frequency of 434 MHz, were determined on two fat/muscle phantoms. One phantom was box-shaped with a flat top layer of 1 cm thick artificial fat and the other one a tube of which the cross-section was elliptically shaped (25 x 36 cm) having a fat equivalent shell of 1 cm thick. For the muscle material a 6 g/l saline (NaCl) solution was used. On the flat rectangular phantom, the effective field size at 1 cm depth in saline was measured to be 4.7 x 13.5 cm, 17.5 x 17.7 cm and 12.5 x 14.0 cm for the 1H-applicator, the 3H-applicator and the 5H-applicator, respectively. For the 3H-and the 5H-applicator, the Specific absorption rate (SAR) distribution at 1 cm depth showed a single maximum of SAR for a thin bolus, which split into two separate "hot spots' for a thicker bolus. The Effective Heating Depths in the phantom with a flat surface were of the order of that of a plane wave (approximately 1.4 cm), whereas a larger EHD of 2.4 cm was achieved below the 3H-applicator bent to fit the elliptical phantom. Due to the large effective field size and the "flatness' of the SAR distribution, the applicators 3H and 5H are suitable to adequately treat large superficial tumours.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8926393     DOI: 10.3109/02656739609022513

Source DB:  PubMed          Journal:  Int J Hyperthermia        ISSN: 0265-6736            Impact factor:   3.914


  7 in total

1.  Performance evaluation of a conformal thermal monitoring sheet sensor array for measurement of surface temperature distributions during superficial hyperthermia treatments.

Authors:  K Arunachalam; P Maccarini; T Juang; C Gaeta; P R Stauffer
Journal:  Int J Hyperthermia       Date:  2008-06       Impact factor: 3.914

Review 2.  Heating technology for malignant tumors: a review.

Authors:  H Petra Kok; Erik N K Cressman; Wim Ceelen; Christopher L Brace; Robert Ivkov; Holger Grüll; Gail Ter Haar; Peter Wust; Johannes Crezee
Journal:  Int J Hyperthermia       Date:  2020       Impact factor: 3.914

3.  Vesicoureteral reflux in children: a phantom study of microwave heating and radiometric thermometry of pediatric bladder.

Authors:  Yngve Birkelund; Øystein Klemetsen; Svein K Jacobsen; Kavitha Arunachalam; Paolo Maccarini; Paul R Stauffer
Journal:  IEEE Trans Biomed Eng       Date:  2011-09-06       Impact factor: 4.538

Review 4.  Conformal microwave array (CMA) applicators for hyperthermia of diffuse chest wall recurrence.

Authors:  Paul R Stauffer; Paolo Maccarini; Kavitha Arunachalam; Oana Craciunescu; Chris Diederich; Titania Juang; Francesca Rossetto; Jaime Schlorff; Andrew Milligan; Joe Hsu; Penny Sneed; Zeljko Vujaskovic
Journal:  Int J Hyperthermia       Date:  2010       Impact factor: 3.914

5.  A thermal monitoring sheet with low influence from adjacent waterbolus for tissue surface thermometry during clinical hyperthermia.

Authors:  Kavitha Arunachalam; Paolo F Maccarini; Paul R Stauffer
Journal:  IEEE Trans Biomed Eng       Date:  2008-10       Impact factor: 4.538

Review 6.  Quality assurance guidelines for superficial hyperthermia clinical trials : II. Technical requirements for heating devices.

Authors:  Hana Dobšíček Trefná; Johannes Crezee; Manfred Schmidt; Dietmar Marder; Ulf Lamprecht; Michael Ehmann; Jacek Nadobny; Josefin Hartmann; Nicolleta Lomax; Sultan Abdel-Rahman; Sergio Curto; Akke Bakker; Mark D Hurwitz; Chris J Diederich; Paul R Stauffer; Gerard C Van Rhoon
Journal:  Strahlenther Onkol       Date:  2017-03-01       Impact factor: 3.621

7.  Modelling Curved Contact Flexible Microstrip Applicators for Patient-Specific Superficial Hyperthermia Treatment Planning.

Authors:  H Petra Kok; Jort Groen; Akke Bakker; Johannes Crezee
Journal:  Cancers (Basel)       Date:  2020-03-11       Impact factor: 6.639

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.